238 related articles for article (PubMed ID: 26526356)
1. A Her2-let-7-β2-AR circuit affects prognosis in patients with Her2-positive breast cancer.
Liu D; Deng Q; Sun L; Wang T; Yang Z; Chen H; Guo L; Liu Y; Ma Y; Guo N; Shi M
BMC Cancer; 2015 Nov; 15():832. PubMed ID: 26526356
[TBL] [Abstract][Full Text] [Related]
2. The β2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells.
Shi M; Liu D; Duan H; Qian L; Wang L; Niu L; Zhang H; Yong Z; Gong Z; Song L; Yu M; Hu M; Xia Q; Shen B; Guo N
Breast Cancer Res Treat; 2011 Jan; 125(2):351-62. PubMed ID: 20237834
[TBL] [Abstract][Full Text] [Related]
3. β2-AR signaling controls trastuzumab resistance-dependent pathway.
Liu D; Yang Z; Wang T; Yang Z; Chen H; Hu Y; Hu C; Guo L; Deng Q; Liu Y; Yu M; Shi M; Du N; Guo N
Oncogene; 2016 Jan; 35(1):47-58. PubMed ID: 25798840
[TBL] [Abstract][Full Text] [Related]
4. Decrease of let-7f in low-dose metronomic Paclitaxel chemotherapy contributed to upregulation of thrombospondin-1 in breast cancer.
Tao WY; Liang XS; Liu Y; Wang CY; Pang D
Int J Biol Sci; 2015; 11(1):48-58. PubMed ID: 25552929
[TBL] [Abstract][Full Text] [Related]
5. Let-7 Status Is Crucial for PARP1 Expression in HER2-Overexpressing Breast Tumors.
Wielgos ME; Rajbhandari R; Cooper TS; Wei S; Nozell S; Yang ES
Mol Cancer Res; 2017 Mar; 15(3):340-347. PubMed ID: 28031413
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA let-7 establishes expression of beta2-adrenergic receptors and dynamically down-regulates agonist-promoted down-regulation.
Wang WC; Juan AH; Panebra A; Liggett SB
Proc Natl Acad Sci U S A; 2011 Apr; 108(15):6246-51. PubMed ID: 21447718
[TBL] [Abstract][Full Text] [Related]
8. Aromatase inhibitor treatment of breast cancer cells increases the expression of let-7f, a microRNA targeting CYP19A1.
Shibahara Y; Miki Y; Onodera Y; Hata S; Chan MS; Yiu CC; Loo TY; Nakamura Y; Akahira J; Ishida T; Abe K; Hirakawa H; Chow LW; Suzuki T; Ouchi N; Sasano H
J Pathol; 2012 Jul; 227(3):357-66. PubMed ID: 22407818
[TBL] [Abstract][Full Text] [Related]
9. β2-AR-induced Her2 transactivation mediated by Erbin confers protection from apoptosis in cardiomyocytes.
Shi M; Zhao M; Hu M; Liu D; Cao H; Qian L; Yang Z; Hu Y; Yu M; Yang S; Ma Y; Guo N
Int J Cardiol; 2013 Aug; 167(4):1570-7. PubMed ID: 22564389
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor decreases CMYC and KRAS expression by upregulating let-7a expression in ER-, PR-, AR+ breast cancer.
Lyu S; Yu Q; Ying G; Wang S; Wang Y; Zhang J; Niu Y
Int J Oncol; 2014 Jan; 44(1):229-37. PubMed ID: 24172884
[TBL] [Abstract][Full Text] [Related]
11. β2-AR activation promotes cleavage and nuclear translocation of Her2 and metastatic potential of cancer cells.
Liu D; Zha L; Liu Y; Zhao X; Xu X; Liu S; Ma W; Zheng J; Shi M
Cancer Sci; 2020 Dec; 111(12):4417-4428. PubMed ID: 33016509
[TBL] [Abstract][Full Text] [Related]
12. Catecholamine-Induced β2-adrenergic receptor activation mediates desensitization of gastric cancer cells to trastuzumab by upregulating MUC4 expression.
Shi M; Yang Z; Hu M; Liu D; Hu Y; Qian L; Zhang W; Chen H; Guo L; Yu M; Song L; Ma Y; Guo N
J Immunol; 2013 Jun; 190(11):5600-8. PubMed ID: 23630346
[TBL] [Abstract][Full Text] [Related]
13. A Novel Effect of β-Adrenergic Receptor on Mammary Branching Morphogenesis and its Possible Implications in Breast Cancer.
Gargiulo L; May M; Rivero EM; Copsel S; Lamb C; Lydon J; Davio C; Lanari C; Lüthy IA; Bruzzone A
J Mammary Gland Biol Neoplasia; 2017 Mar; 22(1):43-57. PubMed ID: 28074314
[TBL] [Abstract][Full Text] [Related]
14. Differential altered expression of let-7a and miR-205 tumor-suppressor miRNAs in different subtypes of breast cancer under treatment with Taxol.
Asghari F; Haghnavaz N; Shanehbandi D; Khaze V; Baradaran B; Kazemi T
Adv Clin Exp Med; 2018 Jul; 27(7):941-945. PubMed ID: 30019863
[TBL] [Abstract][Full Text] [Related]
15. Loss of androgen receptor associated protein 70 (ARA70) expression in a subset of HER2-positive breast cancers.
Kollara A; Kahn HJ; Marks A; Brown TJ
Breast Cancer Res Treat; 2001 Jun; 67(3):245-53. PubMed ID: 11561770
[TBL] [Abstract][Full Text] [Related]
16. A CREB-mediated increase in miRNA let-7f during prolonged β-agonist exposure: a novel mechanism of β
Kim D; Cho S; Woo JA; Liggett SB
FASEB J; 2018 Jul; 32(7):3680-3688. PubMed ID: 29455573
[TBL] [Abstract][Full Text] [Related]
17. β2-microglobulin has a different regulatory molecular mechanism between ER
Chai D; Li K; Du H; Yang S; Yang R; Xu Y; Lian X
BMC Cancer; 2019 Mar; 19(1):223. PubMed ID: 30866857
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA
Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139
[TBL] [Abstract][Full Text] [Related]
19. Junctional adhesion molecule-A is co-expressed with HER2 in breast tumors and acts as a novel regulator of HER2 protein degradation and signaling.
Brennan K; McSherry EA; Hudson L; Kay EW; Hill AD; Young LS; Hopkins AM
Oncogene; 2013 May; 32(22):2799-804. PubMed ID: 22751120
[TBL] [Abstract][Full Text] [Related]
20. Detection of an elevated HER2 expression in MCF-7 breast cancer cells overexpressing estrogen receptor beta1.
Lattrich C; Juhasz-Boess I; Ortmann O; Treeck O
Oncol Rep; 2008 Mar; 19(3):811-7. PubMed ID: 18288420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
